Target intelligence / Profile preview

Niacin-dependent enzyme (null)

Target
null
Molecular classification
Enzyme, Dehydrogenase, Mono-ADP-ribosyltransferase, NAD-dependent deacetylase, ADP-ribosylcyclase, Transferase
01

Overview

Niacin-dependent enzymes comprise a diverse set of more than 400 enzymes that rely on niacin-derived cofactors, NAD and NADP, for their function in redox reactions and metabolic pathways across all tissues[1][2][6]. Major classes include dehydrogenases (central to energy metabolism), poly(ADP-ribose) polymerases (in DNA repair), sirtuins (in gene regulation and aging), ADP-ribosyltransferases, and transferases such as nicotinamide N-methyltransferase[1][3][5]. These enzymes underpin processes such as energy production, DNA repair, cell differentiation, and lipid synthesis, and have roles in disease areas ranging from cardiovascular disease and cancer to neurodegeneration and metabolic disorders. Niacin, through its coenzyme forms, is thus indispensable for cellular health, and dysregulation or deficiency in these pathways can contribute to a variety of pathologies. Therapeutically, these enzyme families are targeted for conditions like hyperlipidemia (niacin), cancer (PARP inhibitors), and aging, but their essentiality and broad activity pose safety and efficacy challenges for drug development and clinical management[1][2][5][6].

Other names
NAD-dependent enzymeNADP-dependent enzymeNiacin coenzyme-dependent enzyme
02

Mechanism of action

Substrate or cofactor provision (niacin-derived coenzymes required for enzymatic activity). Redox reactions (transfer of electrons in metabolic pathways). ADP-ribosylation (protein post-translational modification by PARPs). Deacetylation (sirtuins, affecting gene regulation and metabolism). Methylation (NNMT modulates cellular methylation and NAD levels). Anabolic and catabolic reactions (energy metabolism, cholesterol/fatty acid synthesis).

03

Biological functions

Cellular metabolism (energy release from carbohydrates and fats, oxidation-reduction reactions)DNA repair (via PARPs)Gene silencing and regulation (via sirtuins)Cell cycle regulationCell differentiationCell signaling (intracellular calcium regulation)Fatty acid, cholesterol, and steroid hormone synthesis
04

Disease associations

Cardiovascular diseaseCancerNeurodegenerative disease (Alzheimer's, Parkinson's, Huntington's, ALS)ArthritisSchizophreniaMuscular atrophyMetabolic disease (diabetes, dyslipidemia, obesity)Aging-related disorders
05

Safety considerations

Niacin toxicity (elevated niacin or nicotinamide with supplementation may lead to hepatotoxicity, insulin resistance, or other adverse effects)Interaction with other drugs (e.g. cytochrome P450 enzyme inhibition)Broad effects—targeting these enzymes may have pleiotropic (multiple and not easily predictable) consequences due to their involvement in many fundamental cellular processes
06

Interacting drugs

Niacin (nicotinic acid, vitamin B3)

4 more in the full profile.

07

Biomarkers

Urinary excretion of niacin metabolites (N1-methyl-nicotinamide, N1-methyl-2-pyridone-5-carboxamide for niacin status)Plasma NAD/NADP concentrationActivity/readout of individual enzymes (e.g. sirtuin activity markers, PARP activity markers)

Beyond the preview

Go deeper on Niacin-dependent enzyme (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Niacin-dependent enzyme (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call